Unlock instant, AI-driven research and patent intelligence for your innovation.

Medicinal composition its preparation method and its use in preparing medicine for treating SARS and its complication

A composition and drug technology, applied to a pharmaceutical composition, its preparation method and its use, can solve the problems of low ganglioside content and low activity

Inactive Publication Date: 2006-09-20
TONGHUA TELI JIER PHARM TECH SERVICE CO LTD
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0014] Rabbit meat extracts and rabbit heart extracts, such as Xinxuetong injection, are made by hydrolysis of rabbit muscle and rabbit myocardium, and each milliliter contains less than 1 gram of rabbit muscle, and only contains active polypeptides of muscle tissue, and its activity is low
[0016] The contents of gangliosides in the currently disclosed brain extracts are all low, and although there are also public reports of gangliosides as components of the composition, and pharmaceutical compositions that work synergistically with other components, there is still no There are related reports that it plays a synergistic role with other animal tissues

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal composition its preparation method and its use in preparing medicine for treating SARS and its complication
  • Medicinal composition its preparation method and its use in preparing medicine for treating SARS and its complication
  • Medicinal composition its preparation method and its use in preparing medicine for treating SARS and its complication

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0115] step 1):

[0116] Take 10kg of fresh rabbit muscle, add 20L of water to homogenate, refrigerate at 4°C for 12 hours, filter with 80-mesh nylon cloth, add 0.1% mycoprotease to the filtrate, adjust the pH value to 7.4, and incubate at 45°C for 2.5 hours. The hydrolyzate was centrifuged at 3000 rpm for 20 minutes. The centrifuged supernatant was filtered through a 0.3um filter membrane, and the filtrate was concentrated under reduced pressure to 800ml, which was used as a rabbit muscle extract for future use, wherein the polypeptide content was 8mg / ml.

[0117] Step (2):

[0118] Get 10kg of fresh bovine brain and homogenate with 40L acetone, filter the homogenate with filter paper to obtain 2500g of filter residue, extract the filter residue three times with 10L of chloroform-methanol (1:1) mixture, filter respectively and combine the filtrates, use a rotary evaporator, Evaporate to dryness under reduced pressure at 37°C to obtain 1.25 g of dry matter. The dry matter w...

Embodiment 2

[0129] step 1):

[0130] Take 10kg of fresh deer muscle, add 16L of water to homogenate, refrigerate at 6°C for 14 hours, filter with 80 mesh nylon cloth, add 0.05% mycoprotease to the filtrate, adjust the pH value to 7.2, and keep it warm at 39°C for 4 hours. The hydrolyzate was centrifuged at 3000 rpm for 20 minutes. The centrifuged supernatant was filtered through a 0.3um membrane filter, and the filtrate was concentrated under reduced pressure to 800ml, wherein the polypeptide content was 2.725mg / ml, which was used as deer muscle extract for future use.

[0131] Step (2):

[0132] Take 10kg of fresh bovine brain and homogenate with 35L acetone, filter the homogenate with filter paper to obtain 2500g of filter residue, extract the filter residue three times with 7.5L of chloroform-methanol (5:1) mixture, filter respectively and combine the filtrates, use a rotary evaporator, Evaporate to dryness under reduced pressure at 37°C to obtain 1.25 g of dry matter. The dry matte...

Embodiment 3

[0142] step 1):

[0143] Take 10 kg of fresh rabbit muscle, add 25 L of water to homogenate, refrigerate at 8°C for 16 hours, filter with 80-mesh nylon cloth, add 0.5% mycoprotease to the filtrate, adjust the pH value to 7.6, and incubate at 42°C for 2 hours. The hydrolyzate was centrifuged at 3000 rpm for 20 minutes. The centrifuged supernatant was filtered through a 0.3um membrane filter, and the filtrate was concentrated under reduced pressure to 800ml, in which the polypeptide content was 5mg / ml, which was used as a rabbit muscle extract for future use.

[0144] Step (2):

[0145] Get 10kg of fresh horse brain and homogenate with 30L acetone, filter the homogenate with filter paper to obtain 2500g of filter residue, extract the filter residue three times with 12.5L of chloroform-methanol (20:1) mixture, filter respectively and combine the filtrates, use a rotary evaporator, Evaporate to dryness under reduced pressure at 37°C to obtain 1.25 g of dry matter. The dry matte...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
concentrationaaaaaaaaaa
Login to View More

Abstract

A medicine contains the active polypeptide, ganglioside and hypoxanthine, which are respectively extracted from the muscle tissue, brain tissue and myocardial tissue of the mammal other than man. Its preparing process and its application in preparing the medicines for treating SARS and its complications are also disclosed.

Description

technical field [0001] The present invention relates to a kind of pharmaceutical composition, its preparation method and its use, in particular, to a kind of active polypeptide extracted from the muscle tissue of mammals other than human and extracted from the brain tissue of mammals other than human. The ganglioside and the pharmaceutical composition prepared from the hypoxanthine extracted from the myocardial tissue of mammals other than humans, its preparation method and its medicine for the preparation and treatment of SARS and the dysfunction caused by myocardial and brain diseases use. Background technique [0002] Gangliosides are sialic acid-containing glycosphingolipids, one or more of which terminal sugar groups are N-acetylneuric acid, sialic acid. The membrane lipids of gray matter contain more than 6% gangliosides, which play an important role in nerve conduction. [0003] The clinical medicinal value of gangliosides are: for the functional recovery of central...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K38/02A61K35/34A61P31/14A61P11/00C12P21/00C12P19/44
Inventor 张志
Owner TONGHUA TELI JIER PHARM TECH SERVICE CO LTD